1. Home
  2. MYFW vs CABA Comparison

MYFW vs CABA Comparison

Compare MYFW & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYFW
  • CABA
  • Stock Information
  • Founded
  • MYFW 2002
  • CABA 2017
  • Country
  • MYFW United States
  • CABA United States
  • Employees
  • MYFW N/A
  • CABA 167
  • Industry
  • MYFW Major Banks
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MYFW Finance
  • CABA Health Care
  • Exchange
  • MYFW Nasdaq
  • CABA Nasdaq
  • Market Cap
  • MYFW 216.2M
  • CABA 233.2M
  • IPO Year
  • MYFW 2018
  • CABA 2019
  • Fundamental
  • Price
  • MYFW $23.00
  • CABA $2.55
  • Analyst Decision
  • MYFW Buy
  • CABA Strong Buy
  • Analyst Count
  • MYFW 2
  • CABA 8
  • Target Price
  • MYFW $24.25
  • CABA $13.50
  • AVG Volume (30 Days)
  • MYFW 24.0K
  • CABA 5.4M
  • Earning Date
  • MYFW 10-23-2025
  • CABA 11-07-2025
  • Dividend Yield
  • MYFW N/A
  • CABA N/A
  • EPS Growth
  • MYFW 391.62
  • CABA N/A
  • EPS
  • MYFW 1.28
  • CABA N/A
  • Revenue
  • MYFW $95,514,000.00
  • CABA N/A
  • Revenue This Year
  • MYFW $15.96
  • CABA N/A
  • Revenue Next Year
  • MYFW $13.77
  • CABA N/A
  • P/E Ratio
  • MYFW $17.97
  • CABA N/A
  • Revenue Growth
  • MYFW 19.92
  • CABA N/A
  • 52 Week Low
  • MYFW $17.10
  • CABA $0.99
  • 52 Week High
  • MYFW $24.88
  • CABA $5.46
  • Technical
  • Relative Strength Index (RSI)
  • MYFW 51.02
  • CABA 47.25
  • Support Level
  • MYFW $22.13
  • CABA $2.39
  • Resistance Level
  • MYFW $23.27
  • CABA $3.67
  • Average True Range (ATR)
  • MYFW 0.66
  • CABA 0.34
  • MACD
  • MYFW 0.03
  • CABA -0.06
  • Stochastic Oscillator
  • MYFW 55.21
  • CABA 9.85

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: